Spoken Alpha
LIGAND PHARMACEUTICALS INC
Ligand Pharmaceuticals operates as a biopharmaceutical royalty company that acquires and monetizes royalty interests in mid- to late-stage development and commercial drug products, generating non-dilutive cash flows from a diversified portfolio of over 90 programs.
LIGAND PHARMACEUTICALS INC.
Behavioral analysis
Disclosures
Extracted from SEC 10-K filing, 2026-10-04.
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add LGNXZ, reply to your welcome email and we'll prioritize it.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LGNXZ.
$ curl https://api.spokenalpha.com/v1/companies/LGNXZFAQ
Spoken Alpha indexes LGNXZ's earnings call transcripts at https://spokenalpha.com/companies/LGNXZ. Each call links to attributed speakers and parsed analyst Q&A. LIGAND PHARMACEUTICALS INC's own investor relations page is at https://investor.ligand.com/overview/default.aspx.